Loading…
Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase
The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of...
Saved in:
Published in: | Chemistry : a European journal 2012-12, Vol.18 (49), p.15772-15781 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43 |
---|---|
cites | cdi_FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43 |
container_end_page | 15781 |
container_issue | 49 |
container_start_page | 15772 |
container_title | Chemistry : a European journal |
container_volume | 18 |
creator | Sawa, Ryuichi Takahashi, Yoshiaki Hashizume, Hideki Sasaki, Kazushige Ishizaki, Yoshimasa Umekita, Maya Hatano, Masaki Abe, Hikaru Watanabe, Takumi Kinoshita, Naoko Homma, Yoshiko Hayashi, Chigusa Inoue, Kunio Ohba, Syunichi Masuda, Toru Arakawa, Masayuki Kobayashi, Yoshihiko Hamada, Masa Igarashi, Masayuki Adachi, Hayamitsu Nishimura, Yoshio Akamatsu, Yuzuru |
description | The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of AMM was determined by NMR spectroscopy, X‐ray analysis, chemical degradation, and modification of its functional groups. AMM consists of trans‐decalin, tetramic acid, two unusual sugars (amycolose and amykitanose), and dichloropyrrole carboxylic acid. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is a potent and broad‐spectrum antibiotic against Gram‐positive pathogenic bacteria by inhibiting DNA gyrase and bacterial topoisomerase IV. The target of AMM has been proved to be the DNA gyrase B subunit and its binding mode to DNA gyrase is different from those of novobiocin and coumermycin, the known DNA gyrase inhibitors.
Equilibrium structure: Amycolamicin (AMM) was discovered as a new antibiotic and its absolute structure was determined. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is effective against methicillin‐resistant Staphylococcus aureus and its strains, which are resistant to known DNA gyrase inhibitors. AMM is a potent and selective inhibitor of DNA gyrase and it does not inhibit human topoisomerase II (see figure). |
doi_str_mv | 10.1002/chem.201202645 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1778043062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1439227389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43</originalsourceid><addsrcrecordid>eNqF0c1v0zAYBnALgVgZXDmiSFy4pPP3B7eu27qJUSQo4mg5tsM8krizE1j_-6XqqKZderIPv-eRXj0AvEdwiiDEJ_bGt1MMEYaYU_YCTBDDqCSCs5dgAhUVJWdEHYE3Od9CCBUn5DU4wgRhRSmZgO-zdmNjY9pgQ_e5mBXL-Nc3xWmKxpU_1t72aWiLWdeHKsQ-2OKquxm_feh-F6fG9j4F0xSruI4hx9Ynk_1b8Ko2TfbvHt9j8PPifDW_LK-_La7ms-vSMkpYqaSpJIJWOMw5prUUznnv6trVzmNPlWCVkbVyFXKmMkhYScx4M6-RtNRScgw-7XrXKd4NPve6Ddn6pjGdj0PWSAgJKYEcH6aUKIwFkeowRUpQyRDZ0o_P6G0cUjfePCrJMeQKiVFNd8qmmHPytV6n0Jq00Qjq7YZ6u6HebzgGPjzWDlXr3Z7_H20Eagf-hcZvDtTp-eX516fl5S4bcu_v91mT_mguiGD613Kh5ZezBV6erTQlD_ZXtno</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1186206917</pqid></control><display><type>article</type><title>Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase</title><source>Wiley</source><creator>Sawa, Ryuichi ; Takahashi, Yoshiaki ; Hashizume, Hideki ; Sasaki, Kazushige ; Ishizaki, Yoshimasa ; Umekita, Maya ; Hatano, Masaki ; Abe, Hikaru ; Watanabe, Takumi ; Kinoshita, Naoko ; Homma, Yoshiko ; Hayashi, Chigusa ; Inoue, Kunio ; Ohba, Syunichi ; Masuda, Toru ; Arakawa, Masayuki ; Kobayashi, Yoshihiko ; Hamada, Masa ; Igarashi, Masayuki ; Adachi, Hayamitsu ; Nishimura, Yoshio ; Akamatsu, Yuzuru</creator><creatorcontrib>Sawa, Ryuichi ; Takahashi, Yoshiaki ; Hashizume, Hideki ; Sasaki, Kazushige ; Ishizaki, Yoshimasa ; Umekita, Maya ; Hatano, Masaki ; Abe, Hikaru ; Watanabe, Takumi ; Kinoshita, Naoko ; Homma, Yoshiko ; Hayashi, Chigusa ; Inoue, Kunio ; Ohba, Syunichi ; Masuda, Toru ; Arakawa, Masayuki ; Kobayashi, Yoshihiko ; Hamada, Masa ; Igarashi, Masayuki ; Adachi, Hayamitsu ; Nishimura, Yoshio ; Akamatsu, Yuzuru</creatorcontrib><description>The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of AMM was determined by NMR spectroscopy, X‐ray analysis, chemical degradation, and modification of its functional groups. AMM consists of trans‐decalin, tetramic acid, two unusual sugars (amycolose and amykitanose), and dichloropyrrole carboxylic acid. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is a potent and broad‐spectrum antibiotic against Gram‐positive pathogenic bacteria by inhibiting DNA gyrase and bacterial topoisomerase IV. The target of AMM has been proved to be the DNA gyrase B subunit and its binding mode to DNA gyrase is different from those of novobiocin and coumermycin, the known DNA gyrase inhibitors.
Equilibrium structure: Amycolamicin (AMM) was discovered as a new antibiotic and its absolute structure was determined. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is effective against methicillin‐resistant Staphylococcus aureus and its strains, which are resistant to known DNA gyrase inhibitors. AMM is a potent and selective inhibitor of DNA gyrase and it does not inhibit human topoisomerase II (see figure).</description><identifier>ISSN: 0947-6539</identifier><identifier>EISSN: 1521-3765</identifier><identifier>DOI: 10.1002/chem.201202645</identifier><identifier>PMID: 23129443</identifier><identifier>CODEN: CEUJED</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Antibiotics ; Bacteria ; Bacteria - drug effects ; Binding ; Biophysics ; Chemistry ; Deoxyribonucleic acid ; DNA ; DNA replication ; DNA Topoisomerase IV - antagonists & inhibitors ; DNA Topoisomerase IV - chemistry ; Glucosides - chemistry ; Glucosides - pharmacology ; Inhibitors ; Magnetic Resonance Spectroscopy ; Methyl alcohol ; Microbial Sensitivity Tests ; natural products ; Pathogens ; Pyrroles - chemistry ; Pyrroles - pharmacology ; Spectrum analysis ; Staphylococcus aureus ; structure elucidation ; Topoisomerase II Inhibitors</subject><ispartof>Chemistry : a European journal, 2012-12, Vol.18 (49), p.15772-15781</ispartof><rights>Copyright © 2012 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.</rights><rights>Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43</citedby><cites>FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23129443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sawa, Ryuichi</creatorcontrib><creatorcontrib>Takahashi, Yoshiaki</creatorcontrib><creatorcontrib>Hashizume, Hideki</creatorcontrib><creatorcontrib>Sasaki, Kazushige</creatorcontrib><creatorcontrib>Ishizaki, Yoshimasa</creatorcontrib><creatorcontrib>Umekita, Maya</creatorcontrib><creatorcontrib>Hatano, Masaki</creatorcontrib><creatorcontrib>Abe, Hikaru</creatorcontrib><creatorcontrib>Watanabe, Takumi</creatorcontrib><creatorcontrib>Kinoshita, Naoko</creatorcontrib><creatorcontrib>Homma, Yoshiko</creatorcontrib><creatorcontrib>Hayashi, Chigusa</creatorcontrib><creatorcontrib>Inoue, Kunio</creatorcontrib><creatorcontrib>Ohba, Syunichi</creatorcontrib><creatorcontrib>Masuda, Toru</creatorcontrib><creatorcontrib>Arakawa, Masayuki</creatorcontrib><creatorcontrib>Kobayashi, Yoshihiko</creatorcontrib><creatorcontrib>Hamada, Masa</creatorcontrib><creatorcontrib>Igarashi, Masayuki</creatorcontrib><creatorcontrib>Adachi, Hayamitsu</creatorcontrib><creatorcontrib>Nishimura, Yoshio</creatorcontrib><creatorcontrib>Akamatsu, Yuzuru</creatorcontrib><title>Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase</title><title>Chemistry : a European journal</title><addtitle>Chem. Eur. J</addtitle><description>The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of AMM was determined by NMR spectroscopy, X‐ray analysis, chemical degradation, and modification of its functional groups. AMM consists of trans‐decalin, tetramic acid, two unusual sugars (amycolose and amykitanose), and dichloropyrrole carboxylic acid. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is a potent and broad‐spectrum antibiotic against Gram‐positive pathogenic bacteria by inhibiting DNA gyrase and bacterial topoisomerase IV. The target of AMM has been proved to be the DNA gyrase B subunit and its binding mode to DNA gyrase is different from those of novobiocin and coumermycin, the known DNA gyrase inhibitors.
Equilibrium structure: Amycolamicin (AMM) was discovered as a new antibiotic and its absolute structure was determined. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is effective against methicillin‐resistant Staphylococcus aureus and its strains, which are resistant to known DNA gyrase inhibitors. AMM is a potent and selective inhibitor of DNA gyrase and it does not inhibit human topoisomerase II (see figure).</description><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Bacteria - drug effects</subject><subject>Binding</subject><subject>Biophysics</subject><subject>Chemistry</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA replication</subject><subject>DNA Topoisomerase IV - antagonists & inhibitors</subject><subject>DNA Topoisomerase IV - chemistry</subject><subject>Glucosides - chemistry</subject><subject>Glucosides - pharmacology</subject><subject>Inhibitors</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Methyl alcohol</subject><subject>Microbial Sensitivity Tests</subject><subject>natural products</subject><subject>Pathogens</subject><subject>Pyrroles - chemistry</subject><subject>Pyrroles - pharmacology</subject><subject>Spectrum analysis</subject><subject>Staphylococcus aureus</subject><subject>structure elucidation</subject><subject>Topoisomerase II Inhibitors</subject><issn>0947-6539</issn><issn>1521-3765</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqF0c1v0zAYBnALgVgZXDmiSFy4pPP3B7eu27qJUSQo4mg5tsM8krizE1j_-6XqqKZderIPv-eRXj0AvEdwiiDEJ_bGt1MMEYaYU_YCTBDDqCSCs5dgAhUVJWdEHYE3Od9CCBUn5DU4wgRhRSmZgO-zdmNjY9pgQ_e5mBXL-Nc3xWmKxpU_1t72aWiLWdeHKsQ-2OKquxm_feh-F6fG9j4F0xSruI4hx9Ynk_1b8Ko2TfbvHt9j8PPifDW_LK-_La7ms-vSMkpYqaSpJIJWOMw5prUUznnv6trVzmNPlWCVkbVyFXKmMkhYScx4M6-RtNRScgw-7XrXKd4NPve6Ddn6pjGdj0PWSAgJKYEcH6aUKIwFkeowRUpQyRDZ0o_P6G0cUjfePCrJMeQKiVFNd8qmmHPytV6n0Jq00Qjq7YZ6u6HebzgGPjzWDlXr3Z7_H20Eagf-hcZvDtTp-eX516fl5S4bcu_v91mT_mguiGD613Kh5ZezBV6erTQlD_ZXtno</recordid><startdate>20121203</startdate><enddate>20121203</enddate><creator>Sawa, Ryuichi</creator><creator>Takahashi, Yoshiaki</creator><creator>Hashizume, Hideki</creator><creator>Sasaki, Kazushige</creator><creator>Ishizaki, Yoshimasa</creator><creator>Umekita, Maya</creator><creator>Hatano, Masaki</creator><creator>Abe, Hikaru</creator><creator>Watanabe, Takumi</creator><creator>Kinoshita, Naoko</creator><creator>Homma, Yoshiko</creator><creator>Hayashi, Chigusa</creator><creator>Inoue, Kunio</creator><creator>Ohba, Syunichi</creator><creator>Masuda, Toru</creator><creator>Arakawa, Masayuki</creator><creator>Kobayashi, Yoshihiko</creator><creator>Hamada, Masa</creator><creator>Igarashi, Masayuki</creator><creator>Adachi, Hayamitsu</creator><creator>Nishimura, Yoshio</creator><creator>Akamatsu, Yuzuru</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>K9.</scope><scope>7X8</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TM</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20121203</creationdate><title>Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase</title><author>Sawa, Ryuichi ; Takahashi, Yoshiaki ; Hashizume, Hideki ; Sasaki, Kazushige ; Ishizaki, Yoshimasa ; Umekita, Maya ; Hatano, Masaki ; Abe, Hikaru ; Watanabe, Takumi ; Kinoshita, Naoko ; Homma, Yoshiko ; Hayashi, Chigusa ; Inoue, Kunio ; Ohba, Syunichi ; Masuda, Toru ; Arakawa, Masayuki ; Kobayashi, Yoshihiko ; Hamada, Masa ; Igarashi, Masayuki ; Adachi, Hayamitsu ; Nishimura, Yoshio ; Akamatsu, Yuzuru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Bacteria - drug effects</topic><topic>Binding</topic><topic>Biophysics</topic><topic>Chemistry</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA replication</topic><topic>DNA Topoisomerase IV - antagonists & inhibitors</topic><topic>DNA Topoisomerase IV - chemistry</topic><topic>Glucosides - chemistry</topic><topic>Glucosides - pharmacology</topic><topic>Inhibitors</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Methyl alcohol</topic><topic>Microbial Sensitivity Tests</topic><topic>natural products</topic><topic>Pathogens</topic><topic>Pyrroles - chemistry</topic><topic>Pyrroles - pharmacology</topic><topic>Spectrum analysis</topic><topic>Staphylococcus aureus</topic><topic>structure elucidation</topic><topic>Topoisomerase II Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sawa, Ryuichi</creatorcontrib><creatorcontrib>Takahashi, Yoshiaki</creatorcontrib><creatorcontrib>Hashizume, Hideki</creatorcontrib><creatorcontrib>Sasaki, Kazushige</creatorcontrib><creatorcontrib>Ishizaki, Yoshimasa</creatorcontrib><creatorcontrib>Umekita, Maya</creatorcontrib><creatorcontrib>Hatano, Masaki</creatorcontrib><creatorcontrib>Abe, Hikaru</creatorcontrib><creatorcontrib>Watanabe, Takumi</creatorcontrib><creatorcontrib>Kinoshita, Naoko</creatorcontrib><creatorcontrib>Homma, Yoshiko</creatorcontrib><creatorcontrib>Hayashi, Chigusa</creatorcontrib><creatorcontrib>Inoue, Kunio</creatorcontrib><creatorcontrib>Ohba, Syunichi</creatorcontrib><creatorcontrib>Masuda, Toru</creatorcontrib><creatorcontrib>Arakawa, Masayuki</creatorcontrib><creatorcontrib>Kobayashi, Yoshihiko</creatorcontrib><creatorcontrib>Hamada, Masa</creatorcontrib><creatorcontrib>Igarashi, Masayuki</creatorcontrib><creatorcontrib>Adachi, Hayamitsu</creatorcontrib><creatorcontrib>Nishimura, Yoshio</creatorcontrib><creatorcontrib>Akamatsu, Yuzuru</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Chemistry : a European journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sawa, Ryuichi</au><au>Takahashi, Yoshiaki</au><au>Hashizume, Hideki</au><au>Sasaki, Kazushige</au><au>Ishizaki, Yoshimasa</au><au>Umekita, Maya</au><au>Hatano, Masaki</au><au>Abe, Hikaru</au><au>Watanabe, Takumi</au><au>Kinoshita, Naoko</au><au>Homma, Yoshiko</au><au>Hayashi, Chigusa</au><au>Inoue, Kunio</au><au>Ohba, Syunichi</au><au>Masuda, Toru</au><au>Arakawa, Masayuki</au><au>Kobayashi, Yoshihiko</au><au>Hamada, Masa</au><au>Igarashi, Masayuki</au><au>Adachi, Hayamitsu</au><au>Nishimura, Yoshio</au><au>Akamatsu, Yuzuru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase</atitle><jtitle>Chemistry : a European journal</jtitle><addtitle>Chem. Eur. J</addtitle><date>2012-12-03</date><risdate>2012</risdate><volume>18</volume><issue>49</issue><spage>15772</spage><epage>15781</epage><pages>15772-15781</pages><issn>0947-6539</issn><eissn>1521-3765</eissn><coden>CEUJED</coden><abstract>The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of AMM was determined by NMR spectroscopy, X‐ray analysis, chemical degradation, and modification of its functional groups. AMM consists of trans‐decalin, tetramic acid, two unusual sugars (amycolose and amykitanose), and dichloropyrrole carboxylic acid. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is a potent and broad‐spectrum antibiotic against Gram‐positive pathogenic bacteria by inhibiting DNA gyrase and bacterial topoisomerase IV. The target of AMM has been proved to be the DNA gyrase B subunit and its binding mode to DNA gyrase is different from those of novobiocin and coumermycin, the known DNA gyrase inhibitors.
Equilibrium structure: Amycolamicin (AMM) was discovered as a new antibiotic and its absolute structure was determined. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is effective against methicillin‐resistant Staphylococcus aureus and its strains, which are resistant to known DNA gyrase inhibitors. AMM is a potent and selective inhibitor of DNA gyrase and it does not inhibit human topoisomerase II (see figure).</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>23129443</pmid><doi>10.1002/chem.201202645</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0947-6539 |
ispartof | Chemistry : a European journal, 2012-12, Vol.18 (49), p.15772-15781 |
issn | 0947-6539 1521-3765 |
language | eng |
recordid | cdi_proquest_miscellaneous_1778043062 |
source | Wiley |
subjects | Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antibiotics Bacteria Bacteria - drug effects Binding Biophysics Chemistry Deoxyribonucleic acid DNA DNA replication DNA Topoisomerase IV - antagonists & inhibitors DNA Topoisomerase IV - chemistry Glucosides - chemistry Glucosides - pharmacology Inhibitors Magnetic Resonance Spectroscopy Methyl alcohol Microbial Sensitivity Tests natural products Pathogens Pyrroles - chemistry Pyrroles - pharmacology Spectrum analysis Staphylococcus aureus structure elucidation Topoisomerase II Inhibitors |
title | Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T00%3A38%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amycolamicin:%20A%20Novel%20Broad-Spectrum%20Antibiotic%20Inhibiting%20Bacterial%20Topoisomerase&rft.jtitle=Chemistry%20:%20a%20European%20journal&rft.au=Sawa,%20Ryuichi&rft.date=2012-12-03&rft.volume=18&rft.issue=49&rft.spage=15772&rft.epage=15781&rft.pages=15772-15781&rft.issn=0947-6539&rft.eissn=1521-3765&rft.coden=CEUJED&rft_id=info:doi/10.1002/chem.201202645&rft_dat=%3Cproquest_cross%3E1439227389%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1186206917&rft_id=info:pmid/23129443&rfr_iscdi=true |